Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma, Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07245446
What this trial is testing

Ivonescimab in First-Line ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso 180
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06816966
What this trial is testing

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

Who this might be right for
Small-cell Lung Cancer
Fujian Medical University Union Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00066313
What this trial is testing

ZD6474 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Genzyme, a Sanofi Company
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Large-scale testing (Phase 3)UnknownNCT04535739
What this trial is testing

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Who this might be right for
Small-cell Lung Cancer
Chinese Academy of Medical Sciences 414
Testing effectiveness (Phase 2)Study completedNCT00828139
What this trial is testing

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 189
Testing effectiveness (Phase 2)Study completedNCT00754858
What this trial is testing

Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yonsei University 42
Early research (Phase 1)Looking for participantsNCT06598306
What this trial is testing

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 220
Testing effectiveness (Phase 2)WithdrawnNCT05161533
What this trial is testing

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
University of Washington
Testing effectiveness (Phase 2)Study completedNCT00051506
What this trial is testing

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Who this might be right for
Lung Neoplasms
Eli Lilly and Company
Large-scale testing (Phase 3)Not Yet RecruitingNCT06719336
What this trial is testing

Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Anhui Shi, MD 182
Testing effectiveness (Phase 2)Study completedNCT01076504
What this trial is testing

A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC 81
Large-scale testing (Phase 3)Ended earlyNCT03516084
What this trial is testing

Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 185
Early research (Phase 1)Looking for participantsNCT07545954
What this trial is testing

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerSmall Cell Lung Cancer Extensive Stage
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00240097
What this trial is testing

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Who this might be right for
Non-Small Cell Lung Cancer
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Study completedNCT00028925
What this trial is testing

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Ended earlyNCT00807755
What this trial is testing

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 5
Testing effectiveness (Phase 2)Study completedNCT00004055
What this trial is testing

Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 38
Next Page